| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $48K | +37.1% |
| R&D Expense | $6.4M | +14.9% |
| SG&A Expense | $15.7M | -70.2% |
| Operating Income | -$22.1M | +55.1% |
| Pre-tax Income | -$20.2M | +58.8% |
| Income Tax | $16.0M | +268.2% |
| Net Income | -$36.3M | +8.4% |
| EPS (Basic) | -$0.51 | +8.9% |
| EPS (Diluted) | -$0.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $86.6M | -39.0% |
| Accounts Receivable | $14K | -17.6% |
| Current Assets | $152.3M | -10.2% |
| Total Assets | $153.0M | -19.4% |
| Current Liabilities | $731K | -28.4% |
| Total Liabilities | $731K | -31.5% |
| Stockholders' Equity | $152.2M | -19.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.9M | +67.3% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$38.5M | -3848.5% |
| Financing Cash Flow | -$29K | +85.2% |
| Free Cash Flow | -$16.9M | +67.3% |
| +8.9% |